BenevolentAI, a British-based drug developer, is facing a boardroom coup led by its founder after seeing its shares slump since it floated little more than two years ago.
Baroness Shields has stepped down as chief executive of BenevolentAI as the drugs developer pushes ahead with a widespread restructuring.Shields, 61, a former t
BenevolentAI announces the appointment of biopharma luminary Dr François Nader as Chairman finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.